New rapid test could save lives of febrile children in africa
NCT ID NCT06422338
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a rapid triage test (suPAR) can help doctors make better decisions about admitting or discharging children with fever. Over 5,000 children aged 2 months to 5 years in sub-Saharan Africa will be randomly assigned to standard care or standard care plus the test. The goal is to see if the test reduces inappropriate discharges and improves health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
suPAR point-of-care test
What this could lead to
If successful, this test could help doctors quickly identify which febrile children need hospital care, potentially saving lives and reducing unnecessary admissions.
What could go wrong
This is a large trial, but the test is new and may not improve outcomes over standard care. It is also limited to children in sub-Saharan Africa, so results may not apply elsewhere.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILD, ONLY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CERMEL Centre de Recherches Médicales de Lambaréné
RECRUITINGLambaréné, Moyen-Ogooué Province, 242, Gabon
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mopeia Sede Health Centre
RECRUITINGMopeia, Mozambique
Contact Phone: •••-•••-•••• Email: •••••@•••••